Link Immunotherapeutics

Developer of immunotherapeutics to treat cancer

placeSeattle, Washington, United States calendar_todayFounded 2019 groups15 employees language linkimmunotherapeutics.com

Registered entities

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon